Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.63 |
| ▸ | CA9 | Q16790 | 7/20 | 0.63 |
| ▸ | CA1 | P00915 | 5/20 | 0.63 |
| ▸ | CA2 | P00918 | 5/20 | 0.63 |
| ▸ | CA7 | P43166 | 4/20 | 0.63 |
| ▸ | CA4 | P22748 | 3/20 | 0.63 |
| ▸ | BCHE | P06276 | 2/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CA6 | P23280 | 1/20 | 0.63 |
| ▸ | CA5A | P35218 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.63 |
| ▸ | PARP1 | P09874 | 2/20 | 0.52 |
| ▸ | RET | P07949 | 2/20 | 0.47 |
| ▸ | GRK5 | P34947 | 2/20 | 0.47 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.47 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Saccharin SCHEMBL4199164 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL29191365 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL3816 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL4777123 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL6049140 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL29358404 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL7073018 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL6033672 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL588640 | 0.78 | CA12 (1.00) | CA12CA9CA1CA2CA7 | |
| Saccharin SCHEMBL2526712 | 0.76 | CA12 (0.96) | CA12CA9CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11774853-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-03 | — | — | US | disclosed |
| US-20200241414-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-07-30 | — | — | US | disclosed |
| US-6346526-B1 | CARBAPENICILLIN WITH 1,1-DIOXO-2,3-DIHYDRONAPHTHO(1,8-DE)(1,2)THIAZIN-2-YL-SUBSTITUENT; TREATING STAPHYLOCOCCUS INFECTIONS RESISTANT TO METHICILLIN; SIDE EFFECT REDUCTION | MERCK & CO., INC. | 2002-02-12 | — | — | US | disclosed |
| EP-0001290-B1 | SUBSTITUTED 2,3-DIHYDROBENZ-(D)-ISOTHIAZOLE-1,1-DIOXIDES AND 2,3-DIHYDRONAPHTHO-(1,8-DE)-1,2-THIAZINE-1,1-DIOXIDES | POLAROID CORPORATION (US) | 1984-06-27 | — | — | EP | disclosed |
| US-4359574-A | Thiazine-1,1-dioxide and isothiazole-1,1-dioxide derivatives | POLAROID CORPORATION (US) | 1982-11-16 | — | — | US | disclosed |
| US-4311839-A | Benzisothiazole and naphtho-1,2-thiazine compounds | POLAROID CORPORATION (US) | 1982-01-19 | — | — | US | disclosed |
| US-4283537-A | Thiazine-1,1-dioxide and isothiazole-1,1-dioxide derivatives and process for preparation | POLAROID CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4259493-A | INDICATOR DYES OR PHOTOGRAPHIC LIGHT-SCREENING DYES | POLAROID CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| US-4259498-A | Process for preparing benzisothiazole-1,1-dioxide and naphtho-1,2-thiazine-1,1-dioxide compounds | POLAROID CORPORATION (US) | 1981-03-31 | — | — | US | disclosed |
| US-4255578-A | Synthesis of perhalomethylcarbinol-substituted phenol and naphthol sulfamphthalein dyes from the corresponding triacylated derivatives | POLAROID CORPORATION (US) | 1981-03-10 | — | — | US | disclosed |
| US-4231929-A | Sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-11-04 | — | — | US | disclosed |
| US-4228075-A | Novel sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-10-14 | — | — | US | disclosed |
| US-4210752-A | Synthesis of substituted sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-07-01 | — | — | US | disclosed |
| US-4204061-A | Sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1980-05-20 | — | — | US | disclosed |
| US-4195180-A | Sulfam (na) phthaleins | POLAROID CORPORATION (US) | 1980-03-25 | — | — | US | disclosed |
| US-4191689-A | Benzisothiazole-1,1-dioxide and naphtho-1,2-thiazine-1,1-dioxide compounds | POLAROID CORPORATION (US) | 1980-03-04 | — | — | US | disclosed |
| US-4186001-A | IRREVERSIBLE CLEAVAGE IN ALKALINE SOLUTION TO FORM COLORLESS COMPOUND | POLAROID CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| US-4178446-A | Sulfam(na)phthaleins | POLAROID CORPORATION (US) | 1979-12-11 | — | — | US | disclosed |
| US-4178447-A | Novel synthesis of 3,3-substituted dihydrobenzisothiazole-1,1-dioxides and -2,3-dihydronaphtho-1,2-thiazine-1,1-dioxides | POLAROID CORPORATION (US) | 1979-12-11 | — | — | US | disclosed |
| EP-0001290-A1 | Substituted 2,3-dihydrobenz-(d)-isothiazole-1,1-dioxides and 2,3-dihydronaphtho-(1,8-de)-1,2-thiazine-1,1-dioxides | POLAROID CORPORATION (US) | 1979-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200241414-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | INSR, HNRNPU, HNRNPR | CA12 2165/4885CA9 1249/4885CA1 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.